Top Markets
#1 Siren Siren +38.57%
#2 RedStone RedStone +23.03%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.68%
#4 Cysic Cysic +15.54%
#5 Ocean Protocol Ocean Protocol +15.53%
#6 Verus Coin Verus Coin +13.51%
#7 Arowana Arowana +13.51%
#8 KUB Coin KUB Coin +13.09%
#9 Perle Perle +12.59%
#10 Wiki Cat Wiki Cat +9.55%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
Endymed Ltd Endymed Ltd

Endymed Ltd

ENDY
Rank in Stocks #31814
Endymed Ltd is a medical technology company focused on the global design,... Endymed Ltd is a medical technology company focused on the global design, development, and sale of energy-driven aesthetic treatment systems, catering to both professional practitioners and individual consumers. Its product offerings include the versatile EndyMed PRO, a platform capable of multiple applications. Another key product, PURE 2.0, provides professional-grade skin tightening, body contouring, and functional skin resurfacing. Furthermore, the firm leverages its proprietary 3DEEP radiofrequency technology to deliver a wide array of solutions for cosmetic enhancements, such as diminishing wrinkles, tightening skin, sculpting the body, improving texture, reducing cellulite and overall circumference, treating acne and related scarring, lessening stretch marks, performing RF microneedling, and fractional resurfacing. Established in 2007, the company is headquartered in Freehold, New Jersey.
Share Price
$0.90225185
Last synced: 2025-02-16
Market Cap
$11.99M
Change (1 day)
0.48%
Change (1 year)
0.00%
Country
US
Trade Endymed Ltd (ENDY)

Category

Healthcare
P/E ratio for Endymed Ltd (ENDY)
P/E ratio as of August 2026 TTM: 27.07
According to Endymed Ltd latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 27.07. At the end of 2022 the company had a P/E ratio of 12.14.
P/E ratio history for Endymed Ltd from 2013 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) 27.07 27.92%
2023 21.16 74.36%
2022 12.14 97.99%
2021 6.13 -84.39%
2020 39.27 779.26%
2019 4.47 39.07%
2018 3.21 -219.36%
2017 -2.69 -34.25%
2016 -4.09 -41.61%
2015 -7.01 -101.83%
2014 383.81 -1,057.98%
2013 -40.06 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 32.17%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 28.80%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -20.98%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -22.79%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 52.64 94.49%
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.